Biohaven (BHVN) Depreciation and Depletion (2021 - 2026)
Biohaven (BHVN) reported Depreciation and Depletion of $708000.0 for Q1 2026, down 30.25% on a YoY basis from $1.0 million in Q1 2025, and down 26.25% sequentially from $960000.0 in Q4 2025.
Biohaven (BHVN) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Depreciation and Depletion data on file, last reported at $708000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 30.25% year-over-year to $708000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 4.1% YoY), and the FY2025 full-year result was $4.1 million, up 5.53% from the prior year.
- Depreciation and Depletion retreated to $708000.0 in Q1 2026, from $960000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $1.1 million in Q3 2025 to a low of $209000.0 in Q1 2022.
- A 5-year average of $794176.5 and a median of $941000.0 in 2024 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion soared 273.84% in 2022 and tumbled 30.25% in 2026, its largest moves.
- Tracing BHVN's Depreciation and Depletion over 5 years: stood at $643000.0 in 2022, then soared by 47.43% to $948000.0 in 2023, then gained by 6.01% to $1.0 million in 2024, then fell by 4.48% to $960000.0 in 2025, then declined by 26.25% to $708000.0 in 2026.
- Business Quant data shows BHVN's Depreciation and Depletion at $708000.0 in Q1 2026, $960000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 708,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 708,000.00 |
| Mar 31, 2026 | 708,000.00 |
| Dec 31, 2025 | 960,000.00 |
| Dec 31, 2025 | 960,000.00 |
| Sep 30, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 977,000.00 |
| Jun 30, 2024 | 977,000.00 |
| Mar 31, 2024 | 941,000.00 |
| Mar 31, 2024 | 941,000.00 |
| Dec 31, 2023 | 948,000.00 |
| Dec 31, 2023 | 948,000.00 |